Druggable	Report_C1	Report_C2	Tumor_VAF	Normal_VAF	DP_T	DP_N	SF_TVAF	SF_TDP	CHROM	Start	End	REF	ALT	FILTER	Gene	Transcript	Exon/Intron_Number	cHGVS	pHGVS	Type_Annotation	CLNSIG	CLNCONF	CLNDN	MPOS	POSD
1	NRAS(0.1%)	exon4,c.437C>T,p.A146V	0.001301	0.0008571	4745|6	7815|7	0.00102	20647|21	1	115252203	115252203	G	A	clustered_events,normal_artifact,orientation,strand_bias,weak_evidence	NRAS	NM_002524.5	4	c.437C>T	p.Ala146Val	missense_variant				41	0.0
1	NRAS(0.1%)	exon4,c.436G>T,p.A146S	0.001081	0.0006212	4756|5	7787|6	0.00178	20707|37	1	115252204	115252204	C	A	clustered_events,orientation	NRAS	NM_002524.5	4	c.436G>T	p.Ala146Ser	missense_variant				39	0.0
1	NRAS(0.2%)	exon4,c.436G>A,p.A146T	0.001659	0.0002494	4756|8	7787|2	0.00058	20707|12	1	115252204	115252204	C	T	clustered_events,orientation	NRAS	NM_002524.5	4	c.436G>A	p.Ala146Thr	missense_variant				52	0.0
1	NRAS(0.0%)	exon3,c.182A>T,p.Q61L	0.0004289	0.0003165	3043|3	5965|2	0.00173	12137|21	1	115256529	115256530	T	A	clustered_events,weak_evidence	NRAS	NM_002524.5	3	c.182A>T	p.Gln61Leu	missense_variant	Pathogenic/Likely_pathogenic		Hepatocellular_carcinoma|Acute_myeloid_leukemia|Melanoma|Adrenocortical_carcinoma|B-cell_chronic_lymphocytic_leukemia|Transitional_cell_carcinoma_of_the_bladder|Multiple_myeloma|Renal_cell_carcinoma,_papillary,_1|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Non-small_cell_lung_carcinoma|Neoplasm_of_brain|Adenocarcinoma_of_stomach|Neoplasm_of_the_thyroid_gland|Nasopharyngeal_Neoplasms|Neoplasm_of_the_large_intestine|Ovarian_Serous_Cystadenocarcinoma|Glioblastoma|Malignant_neoplasm_of_body_of_uterus	69	0.0
1	NRAS(0.1%)	exon3,c.175G>A,p.A59T	0.00121	0.0003272	2877|3	5654|1	0.00052	11612|6	1	115256536	115256536	C	T	clustered_events,orientation,strand_bias,weak_evidence	NRAS	NM_002524.5	3	c.175G>A	p.Ala59Thr	missense_variant	Likely_pathogenic		not_provided	37	0.0
1	NRAS(0.1%)	exon2,c.38G>T,p.G13V	0.0006392	0.0002358	7310|5	10082|3	0.00171	36268|62	1	115258744	115258745	C	A	clustered_events,orientation,weak_evidence	NRAS	NM_002524.5	2	c.38G>T	p.Gly13Val	missense_variant	Pathogenic/Likely_pathogenic		Acute_myeloid_leukemia|Neoplasm|Melanoma|Medulloblastoma|Transitional_cell_carcinoma_of_the_bladder|Multiple_myeloma|Malignant_melanoma_of_skin|Non-Hodgkin_lymphoma|Adenocarcinoma_of_stomach|Neoplasm_of_the_large_intestine|Myelodysplastic_syndrome	36	0.0
1	NRAS(0.1%)	exon2,c.38G>A,p.G13D	0.0006874	0.0001308	7310|5	10082|0	0.00055	36268|20	1	115258744	115258745	C	T	clustered_events,orientation,weak_evidence	NRAS	NM_002524.5	2	c.38G>A	p.Gly13Asp	missense_variant	Pathogenic/Likely_pathogenic		Acute_myeloid_leukemia|Melanoma|Medulloblastoma|Transitional_cell_carcinoma_of_the_bladder|Multiple_myeloma|Malignant_melanoma_of_skin|Juvenile_myelomonocytic_leukemia|Non-Hodgkin_lymphoma|Adenocarcinoma_of_stomach|Neoplasm_of_the_large_intestine|Noonan_syndrome_6|RAS-associated_autoimmune_leukoproliferative_disorder|Myelodysplastic_syndrome|Acute_megakaryoblastic_leukemia_in_down_syndrome|not_provided	49	0.0
1	NRAS(0.1%)	exon2,c.37G>T,p.G13C	0.0008848	0.0001317	7310|8	10079|4	0.00175	36493|64	1	115258745	115258745	C	A	clustered_events,orientation,strand_bias,weak_evidence	NRAS	NM_002524.5	2	c.37G>T	p.Gly13Cys	missense_variant	Pathogenic		Melanoma	54	0.0
1	NRAS(0.0%)	exon2,c.35G>T,p.G12V	0.0003241	0.0003054	7314|3	10052|3	0.00097	35989|35	1	115258747	115258748	C	A	clustered_events,orientation,weak_evidence	NRAS	NM_002524.5	2	c.35G>T	p.Gly12Val	missense_variant	Pathogenic/Likely_pathogenic		Acute_myeloid_leukemia|Melanoma|Multiple_myeloma|Malignant_melanoma_of_skin|Adenocarcinoma_of_stomach|Neoplasm_of_the_large_intestine|Noonan_syndrome_6|Myelodysplastic_syndrome|Noonan_syndrome|Rasopathy|Malignant_neoplasm_of_body_of_uterus|not_provided	20	0.0
1	NRAS(0.1%)	exon2,c.34G>T,p.G12C	0.001022	0.0003382	7261|8	9978|4	0.00127	36058|46	1	115258748	115258748	C	A	clustered_events,orientation,strand_bias,weak_evidence	NRAS	NM_002524.5	2	c.34G>T	p.Gly12Cys	missense_variant	Pathogenic		Acute_myeloid_leukemia|Melanoma|Multiple_myeloma|Malignant_melanoma_of_skin|Non-small_cell_lung_carcinoma|Adenocarcinoma_of_stomach|Neoplasm_of_the_large_intestine|Myelodysplastic_syndrome|Malignant_neoplasm_of_body_of_uterus|not_provided	42	0.0
	LORICRIN(0.4%)	exon2,c.60_161del,p.G21_S54del	0.003513	0.001696	1342|3	909|1	*	0|0	1	153233481	153233583	CCTCTGGCGGCGGTGGCGGTGGCGGCGGCAGCGGCGGTGGTGGCTGCGGCTTCTTCGGCGGCGGCGGCTCAGGGGGCGGTAGCAGCGGTTCTGGCTGCGGCTA	C	low_allele_frac	LORICRIN	NM_000427.3	2	c.60_161del	p.Gly21_Ser54del	disruptive_inframe_deletion				27	0.0
-	MSH2(18.3%)	exon2,c.212-4del	0.183	0.172	177|57	347|113	0.16667	405|81	2	47635523	47635524	CT	C	germline,multiallelic,normal_artifact,slippage,suspected_bg	MSH2	NM_000251.3	1	c.212-4del		splice_region_variant&intron_variant	Benign/Likely_benign		Lynch_syndrome_I|Hereditary_cancer-predisposing_syndrome|not_specified|not_provided	39	0.0
-	MSH2(10.4%)	exon2,c.212-4dup	0.104	0.095	177|37	347|61	0.14557	405|69	2	47635523	47635524	CT	CTT	germline,multiallelic,normal_artifact,slippage,suspected_bg	MSH2	NM_000251.3	1	c.212-4dup		splice_region_variant&intron_variant	Benign		Lynch_syndrome_I|Hereditary_cancer-predisposing_syndrome|not_specified|Breast_and/or_ovarian_cancer	42	0.0
-	MSH6(5.7%)	exon5,c.3261del,p.F1088fs	0.057	0.053	3340|243	5258|329	0.04648	10729|523	2	48030639	48030640	AC	A	normal_artifact,slippage,suspected_bg	MSH6	NM_000179.3	5	c.3261del	p.Phe1088fs	frameshift_variant	Pathogenic		Lynch-like_syndrome|Endometrial_carcinoma|Carcinoma_of_colon|Lynch_syndrome|Hereditary_nonpolyposis_colorectal_cancer_type_5|Hereditary_cancer-predisposing_syndrome|Mismatch_repair_cancer_syndrome_3|Hereditary_nonpolyposis_colorectal_neoplasms|not_provided	43	0.0
	LRP1B(7.3%)	exon55,c.8730C>T,p.C2910=	0.073	0.007879	85|5	303|1	0.04545	105|5	2	141259376	141259376	G	A	distinguished	LRP1B	NM_018557.3	55	c.8730C>T	p.Cys2910=	synonymous_variant				51	0.0
	COBLL1(0.7%)	exon12,c.2681G>T,p.R894L	0.006662	0.0004901	1273|8	3034|2	0.00652	2744|18	2	165551335	165551335	C	A	low_allele_frac	COBLL1	NM_014900.5	12	c.2681G>T	p.Arg894Leu	missense_variant				19	0.0
1	IDH1(0.1%)	exon4,c.394C>T,p.R132C	0.001466	0.001171	2953|4	7069|9	0.00181	11054|20	2	209113113	209113113	G	A	clustered_events,normal_artifact,orientation,strand_bias,weak_evidence	IDH1	NM_005896.4	4	c.394C>T	p.Arg132Cys	missense_variant	Pathogenic/Likely_pathogenic		Hepatocellular_carcinoma|Acute_myeloid_leukemia|Medulloblastoma|Transitional_cell_carcinoma_of_the_bladder|Multiple_myeloma|Astrocytoma|Breast_neoplasm|Brainstem_glioma|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Neoplasm_of_brain|Neoplasm_of_the_large_intestine|Adenoid_cystic_carcinoma|Adenocarcinoma_of_prostate|Glioblastoma|Myelodysplastic_syndrome|not_provided	31	0.0
	UGT1A1(1.7%)	exon,c.-55_-54insAT	0.017	0.014	5978|128	6468|128	0.02097	35816|767	2	234668879	234668883	CATAT	CATATAT	clustered_events,multiallelic,normal_artifact,background	UGT1A1	NM_000463.3		c.-55_-54insAT		upstream_gene_variant	Conflicting_interpretations_of_pathogenicity|_drug_response|_other	Pathogenic(5)|_Benign(4)	Gilbert_syndrome|Lucey-Driscoll_syndrome|Crigler-Najjar_syndrome,_type_II|Crigler-Najjar_syndrome_type_1|Bilirubin,_serum_level_of,_quantitative_trait_locus_1|Irinotecan_response|not_specified|not_provided	43	0.0
2	FANCD2(7.0%)	exon6,c.378-5del	0.07	0.065	258|20	688|48	0.05928	365|23	3	10076842	10076843	CT	C	normal_artifact,slippage,background	FANCD2	NM_033084.6	5	c.378-5del		splice_region_variant&intron_variant				46	0.0
	TGFBR2(13.0%)	exon4,c.458del,p.K153fs	0.13	0.083	386|62	1031|102	0.10882	606|74	3	30691871	30691872	GA	G	normal_artifact,slippage,suspected_bg	TGFBR2	NM_001024847.2	4	c.458del	p.Lys153fs	frameshift_variant	Conflicting_interpretations_of_pathogenicity	Likely_pathogenic(1)|_Benign(3)|_Likely_benign(1)	Loeys-Dietz_syndrome|Familial_thoracic_aortic_aneurysm_and_aortic_dissection|not_specified|Cardiovascular_phenotype|not_provided	41	0.0
	ANO10(4.1%)	exon2,c.132del,p.D45fs	0.041	0.044	1815|88	4299|230	0.04066	5875|249	3	43647212	43647213	CT	C	multiallelic,normal_artifact,slippage,suspected_bg	ANO10	NM_018075.5	2	c.132del	p.Asp45fs	frameshift_variant	Pathogenic		not_provided	47	0.0
	ANO10(2.1%)	exon2,c.132dup,p.D45fs	0.021	0.022	1815|49	4299|133	0.03499	5875|213	3	43647212	43647213	CT	CTT	multiallelic,normal_artifact,slippage,suspected_bg	ANO10	NM_018075.5	2	c.132dup	p.Asp45fs	frameshift_variant	Pathogenic/Likely_pathogenic		Abnormal_central_motor_function|Spinocerebellar_ataxia,_autosomal_recessive_10|Autosomal_recessive_cerebellar_ataxia|not_provided	43	0.0
	ATR(7.6%)	exon10,c.2320del,p.I774fs	0.076	0.072	2113|205	5313|475	0.06195	6572|434	3	142274739	142274741	ATT	AT	multiallelic,normal_artifact,slippage,suspected_bg	ATR	NM_001184.4	10	c.2320del	p.Ile774fs	frameshift_variant	Pathogenic		Endometrial_neoplasm|not_provided	46	0.0
	ATR(2.8%)	exon10,c.2320dup,p.I774fs	0.028	0.023	2113|91	5313|170	0.05139	6572|356	3	142274739	142274741	ATT	ATTT	multiallelic,normal_artifact,slippage,suspected_bg	ATR	NM_001184.4	10	c.2320dup	p.Ile774fs	frameshift_variant	Pathogenic		not_provided	48	0.0
1	FGFR3(0.2%)	exon9,c.1108G>T,p.G370C	0.002185	0.0006644	1379|3	1910|0	0.00112	2678|3	4	1806089	1806089	G	T	clustered_events,orientation,strand_bias,weak_evidence	FGFR3	NM_000142.5	9	c.1108G>T	p.Gly370Cys	missense_variant	Pathogenic		Bladder_carcinoma|Epidermal_nevus|Thanatophoric_dysplasia_type_1|not_provided	47	0.0
	MSH3(1.4%)	exon7,c.1148del,p.K383fs	0.014	0.014	2768|44	5874|103	0.01434	8524|124	5	79970914	79970915	CA	C	multiallelic,normal_artifact,slippage,suspected_bg	MSH3	NM_002439.5	7	c.1148del	p.Lys383fs	frameshift_variant	Pathogenic		Endometrial_carcinoma|Hereditary_cancer-predisposing_syndrome|Familial_adenomatous_polyposis_4|not_provided	38	0.0
	MSH3(1.3%)	exon7,c.1148dup,p.N385fs	0.013	0.012	2768|57	5874|89	0.01842	8524|160	5	79970914	79970915	CA	CAA	multiallelic,normal_artifact,slippage,suspected_bg	MSH3	NM_002439.5	7	c.1148dup	p.Asn385fs	frameshift_variant	Pathogenic		not_provided	43	0.0
-	APC(11.8%)	exon5,c.423-4del	0.118	0.186	123|24	329|100	0.16598	201|40	5	112111309	112111310	TA	T	germline,multiallelic,normal_artifact,slippage,suspected_bg	APC	NM_000038.6	4	c.423-4del		splice_region_variant&intron_variant	Benign/Likely_benign		Malignant_Colorectal_Neoplasm|Hereditary_cancer-predisposing_syndrome|Familial_adenomatous_polyposis_1|not_specified|not_provided	45	0.0
-	APC(9.3%)	exon5,c.423-4dup	0.093	0.094	123|19	329|51	0.09459	201|21	5	112111309	112111310	TA	TAA	germline,multiallelic,normal_artifact,slippage,suspected_bg	APC	NM_000038.6	4	c.423-4dup		splice_region_variant&intron_variant	Benign		Familial_adenomatous_polyposis_1|not_specified	36	0.0
-	APC(53.3%)	exon14,c.1660C>T,p.R554*	0.533	0.001764	244|278	1349|1	0.52874	369|414	5	112164586	112164586	C	T	PASS	APC	NM_000038.6	14	c.1660C>T	p.Arg554*	stop_gained	Pathogenic		Hepatocellular_carcinoma|Neoplasm_of_stomach|Carcinoma_of_colon|Hereditary_cancer-predisposing_syndrome|Familial_multiple_polyposis_syndrome|Familial_adenomatous_polyposis_1|Desmoid_disease,_hereditary|Colorectal_cancer,_susceptibility_to|not_provided	40	0.0
	RAD50(5.0%)	exon13,c.2165del,p.K722fs	0.05	0.055	2620|168	5486|369	0.04515	10510|497	5	131931451	131931452	TA	T	multiallelic,normal_artifact,slippage,suspected_bg	RAD50	NM_005732.4	13	c.2165del	p.Lys722fs	frameshift_variant	Pathogenic		Nijmegen_breakage_syndrome-like_disorder|Hereditary_cancer-predisposing_syndrome	44	0.0
	RAD50(1.2%)	exon13,c.2165dup,p.E723fs	0.012	0.016	2620|55	5486|148	0.02847	10510|308	5	131931451	131931452	TA	TAA	multiallelic,normal_artifact,slippage,suspected_bg	RAD50	NM_005732.4	13	c.2165dup	p.Glu723fs	frameshift_variant	Pathogenic		Nijmegen_breakage_syndrome-like_disorder|Hereditary_cancer-predisposing_syndrome|Breast_and/or_ovarian_cancer|not_provided	44	0.0
1	EGFR(0.0%)	exon18,c.2125G>A,p.E709K	0.0004626	0.0002841	6230|3	4700|0	0.00058	17259|10	7	55241677	55241677	G	A	clustered_events,strand_bias,weak_evidence	EGFR	NM_005228.5	18	c.2125G>A	p.Glu709Lys	missense_variant	drug_response		Tyrosine_kinase_inhibitor_response	37	0.0
1	EGFR(0.1%)	exon18,c.2125G>C,p.E709Q	0.0005573	0.0002841	6230|3	4700|0	0.00052	17259|9	7	55241677	55241677	G	C	clustered_events,strand_bias,weak_evidence	EGFR	NM_005228.5	18	c.2125G>C	p.Glu709Gln	missense_variant				37	0.0
1	EGFR(0.1%)	exon18,c.2153T>A,p.L718Q	0.001129	0.0003467	4698|7	3650|2	0.00261	12251|32	7	55241705	55241705	T	A	clustered_events,orientation,strand_bias,weak_evidence	EGFR	NM_005228.5	18	c.2153T>A	p.Leu718Gln	missense_variant				41	0.0
1	EGFR(0.1%)	exon18,c.2155G>T,p.G719C	0.0007947	0.0003447	4616|4	3605|0	0.00183	11976|22	7	55241707	55241707	G	T	clustered_events,orientation,strand_bias,weak_evidence	EGFR	NM_005228.5	18	c.2155G>T	p.Gly719Cys	missense_variant	Pathogenic/Likely_pathogenic|_drug_response		Lung_adenocarcinoma|Non-small_cell_lung_carcinoma|Glioblastoma|Nonsmall_cell_lung_cancer,_response_to_tyrosine_kinase_inhibitor_in,_somatic	34	0.0
1	EGFR(0.1%)	exon18,c.2156G>A,p.G719D	0.0007911	0.0005391	4535|4	3534|1	0.00128	11732|15	7	55241708	55241708	G	A	clustered_events,weak_evidence	EGFR	NM_005228.5	18	c.2156G>A	p.Gly719Asp	missense_variant	Likely_pathogenic		Lung_adenocarcinoma|Non-small_cell_lung_carcinoma|Squamous_cell_lung_carcinoma|Glioblastoma	39	0.0
1	EGFR(0.0%)	exon19,c.2236_2250del,p.E746_A750del	0.0001637	0.0001691	8780|1	7640|0	0.00000	24847|0	7	55242465	55242480	GGAATTAAGAGAAGCA	G	clustered_events,weak_evidence	EGFR	NM_005228.5	19	c.2236_2250del	p.Glu746_Ala750del	conservative_inframe_deletion	Pathogenic		Tyrosine_kinase_inhibitor_response|not_provided	1	0.0
1	EGFR(0.1%)	exon20,c.2303G>T,p.S768I	0.0006027	0.0003121	6299|3	4467|0	0.00091	15287|14	7	55249005	55249005	G	T	clustered_events,orientation,strand_bias,weak_evidence	EGFR	NM_005228.5	20	c.2303G>T	p.Ser768Ile	missense_variant	Pathogenic		Carcinoma_of_esophagus|Non-small_cell_lung_carcinoma|Squamous_cell_lung_carcinoma	30	0.0
1	EGFR(0.1%)	exon20,c.2369C>T,p.T790M	0.0007243	0.0005158	6662|4	4759|1	0.00064	15612|10	7	55249071	55249071	C	T	clustered_events,orientation,strand_bias,weak_evidence	EGFR	NM_005228.5	20	c.2369C>T	p.Thr790Met	missense_variant	drug_response		Non-small_cell_lung_carcinoma|Lung_carcinoma|Lung_cancer|Hereditary_cancer-predisposing_syndrome|Nonsmall_cell_lung_cancer,_resistance_to_tyrosine_kinase_inhibitor_in|EGFR-related_lung_cancer|Tyrosine_kinase_inhibitor_response|erlotinib_response_-_Efficacy|gefitinib_response_-_Efficacy|not_provided	31	0.0
1	EGFR(0.0%)	exon20,c.2374C>T,p.L792F	0.0003592	0.0002846	6638|3	4742|0	0.00019	15932|3	7	55249076	55249076	C	T	clustered_events,strand_bias,weak_evidence	EGFR	NM_005228.5	20	c.2374C>T	p.Leu792Phe	missense_variant	Uncertain_significance		EGFR-related_lung_cancer	14	0.0
1	EGFR(0.1%)	exon20,c.2375T>A,p.L792H	0.0008539	0.0002879	6582|9	4707|3	0.00259	15773|41	7	55249077	55249077	T	A	base_qual,clustered_events,strand_bias,weak_evidence	EGFR	NM_005228.5	20	c.2375T>A	p.Leu792His	missense_variant				45	0.0
1	EGFR(0.1%)	exon20,c.2386G>A,p.G796S	0.0007776	0.0005768	6500|4	4596|2	0.00087	15000|13	7	55249088	55249088	G	A	clustered_events,strand_bias,weak_evidence	EGFR	NM_005228.5	20	c.2386G>A	p.Gly796Ser	missense_variant	Conflicting_interpretations_of_pathogenicity	Likely_pathogenic(1)|_Uncertain_significance(1)	EGFR-related_lung_cancer|not_provided	17	0.0
1	EGFR(0.2%)	exon20,c.2387G>A,p.G796D	0.002187	0.0009118	6487|14	4573|5	0.00357	15341|55	7	55249089	55249089	G	A	clustered_events,orientation,weak_evidence	EGFR	NM_005228.5	20	c.2387G>A	p.Gly796Asp	missense_variant	Uncertain_significance		EGFR-related_lung_cancer	37	0.0
1	EGFR(0.0%)	exon20,c.2389T>A,p.C797S	0.0002313	0.0002961	6403|4	4495|2	0.00258	15070|39	7	55249091	55249091	T	A	base_qual,clustered_events,strand_bias,weak_evidence	EGFR	NM_005228.5	20	c.2389T>A	p.Cys797Ser	missense_variant	not_provided		Non-small_cell_lung_carcinoma	63	0.0
1	EGFR(0.1%)	exon20,c.2392C>A,p.L798I	0.0006776	0.0003011	6257|5	4375|0	0.00110	14553|16	7	55249094	55249094	C	A	clustered_events,strand_bias,weak_evidence	EGFR	NM_005228.5	20	c.2392C>A	p.Leu798Ile	missense_variant				15	0.0
1	EGFR(0.0%)	exon21,c.2573T>G,p.L858R	0.0002998	0.0006825	5200|5	4002|6	0.00201	10428|21	7	55259515	55259515	T	G	base_qual,clustered_events,strand_bias,weak_evidence	EGFR	NM_005228.5	21	c.2573T>G	p.Leu858Arg	missense_variant	drug_response		Lung_adenocarcinoma|Non-small_cell_lung_carcinoma|Lung_carcinoma|Adenocarcinoma_of_lung,_response_to_tyrosine_kinase_inhibitor_in,_somatic|Nonsmall_cell_lung_cancer,_response_to_tyrosine_kinase_inhibitor_in,_somatic|Erlotinib_response|Gefitinib_response|Tyrosine_kinase_inhibitor_response|gefitinib_response_-_Efficacy	44	0.0
1	EGFR(0.0%)	exon21,c.2582T>A,p.L861Q	0.0003103	0.001203	4936|3	3803|7	0.00194	9799|19	7	55259524	55259524	T	A	base_qual,clustered_events,weak_evidence	EGFR	NM_005228.5	21	c.2582T>A	p.Leu861Gln	missense_variant	Pathogenic/Likely_pathogenic|_drug_response		Lung_adenocarcinoma|Non-small_cell_lung_carcinoma|Squamous_cell_lung_carcinoma|Tyrosine_kinase_inhibitor_response	54	0.0
	THAP5(0.4%)	exon3,c.306G>T,p.K102N	0.003747	0.0001491	3607|14	8902|1	0.00592	13929|83	7	108205517	108205517	C	A	strand_bias,low_allele_frac	THAP5	NM_001130475.3	3	c.306G>T	p.Lys102Asn	missense_variant				40	0.0
1	MET(0.0%)	exon14,c.3007T>A,p.Y1003N	0.0003371	0.0001435	6591|3	9392|3	0.00216	41659|90	7	116412022	116412022	T	A	base_qual,clustered_events,orientation,strand_bias,weak_evidence	MET	NM_000245.4	14	c.3007T>A	p.Tyr1003Asn	missense_variant				38	0.0
1	MET(0.1%)	exon14,c.3008A>G,p.Y1003C	0.0006059	0.0005322	6660|4	9491|5	0.00038	41970|16	7	116412023	116412023	A	G	clustered_events,normal_artifact,strand_bias,weak_evidence	MET	NM_000245.4	14	c.3008A>G	p.Tyr1003Cys	missense_variant				24	0.0
1	MET(0.0%)	exon14,c.3028G>C,p.D1010H	0.0003886	0.0001393	6729|4	9560|1	0.00081	41853|34	7	116412043	116412043	G	C	clustered_events,orientation,strand_bias,weak_evidence	MET	NM_000245.4	14	c.3028G>C	p.Asp1010His	missense_variant&splice_region_variant				26	0.0
1	MET(0.0%)	exon14,c.3028G>T,p.D1010Y	0.0003256	0.000143	6729|6	9560|10	0.00421	41853|177	7	116412043	116412043	G	T	clustered_events,orientation,strand_bias,weak_evidence	MET	NM_000245.4	14	c.3028G>T	p.Asp1010Tyr	missense_variant&splice_region_variant				27	0.0
1	MET(0.1%)	exon14,c.3028+1G>A	0.0006809	0.0001626	6727|4	9551|1	0.00069	42005|29	7	116412044	116412044	G	A	clustered_events,orientation,strand_bias,weak_evidence	MET	NM_000245.4	14	c.3028+1G>A		splice_donor_variant&intron_variant	not_provided		not_provided	22	0.0
1	MET(0.1%)	exon14,c.3028+2T>C	0.0005513	0.000363	6683|3	9488|3	0.00041	41791|17	7	116412045	116412045	T	C	clustered_events,orientation,strand_bias,weak_evidence	MET	NM_000245.4	14	c.3028+2T>C		splice_donor_variant&intron_variant	not_provided		not_provided	33	0.0
1	BRAF(0.2%)	exon15,c.1801A>G,p.K601E	0.001575	0.0002142	3607|4	6210|1	0.00055	14646|8	7	140453134	140453134	T	C	clustered_events,orientation,strand_bias,weak_evidence	BRAF	NM_004333.6	15	c.1801A>G	p.Lys601Glu	missense_variant	Pathogenic		Neoplasm|Melanoma|B-cell_chronic_lymphocytic_leukemia|Thyroid_cancer,_nonmedullary,_2|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Non-small_cell_lung_carcinoma|Adenocarcinoma_of_stomach|Neoplasm_of_the_thyroid_gland|Carcinoma_of_colon|Adenocarcinoma_of_prostate|Malignant_neoplasm_of_body_of_uterus	33	0.0
	BRAF(0.2%)	exon15,c.1799T>C,p.V600A	0.001526	0.0003435	3573|5	6149|1	0.00069	14440|10	7	140453136	140453137	A	G	clustered_events,weak_evidence,low_allele_frac	BRAF	NM_004333.6	15	c.1799T>C	p.Val600Ala	missense_variant	Likely_pathogenic		Melanoma	22	0.0
	BRAF(0.1%)	exon15,c.1796C>T,p.T599I	0.001246	0.0007045	3540|4	6109|4	0.00070	14372|10	7	140453139	140453139	G	A	clustered_events,orientation,strand_bias,weak_evidence,low_allele_frac	BRAF	NM_004333.6	15	c.1796C>T	p.Thr599Ile	missense_variant	Pathogenic		Neoplasm|Melanoma|Cardiofaciocutaneous_syndrome_1|Noonan_syndrome|Rasopathy|not_provided	48	0.0
-	KMT2C(2.0%)	exon38,c.8390dup,p.E2798fs	0.02	0.02	4655|130	8332|207	0.03777	20356|799	7	151874147	151874148	CT	CTT	multiallelic,normal_artifact,slippage,suspected_bg	KMT2C	NM_170606.3	38	c.8390dup	p.Glu2798fs	frameshift_variant	Pathogenic		not_provided	37	0.0
	PREX2(5.3%)	exon2,c.151C>A,p.H51N	0.053	0.004717	118|6	297|0	0.04027	143|6	8	68930090	68930090	C	A	PASS	PREX2	NM_024870.4	2	c.151C>A	p.His51Asn	missense_variant				33	0.0
	NBN(0.2%)	exon11,c.1616C>A,p.S539Y	0.002091	0.0002857	4634|11	9555|3	0.00466	22237|104	8	90965701	90965701	G	T	strand_bias,low_allele_frac	NBN	NM_002485.5	11	c.1616C>A	p.Ser539Tyr	missense_variant				56	0.0
	RET(0.1%)	exon11,c.1900T>A,p.C634S	0.0006751	0.0003749	6611|9	7824|7	0.00373	29343|110	10	43609948	43609948	T	A	strand_bias,weak_evidence,low_allele_frac	RET	NM_020975.6	11	c.1900T>A	p.Cys634Ser	missense_variant	Pathogenic		Multiple_endocrine_neoplasia,_type_2	25	0.0
1	RET(0.1%)	exon11,c.1902C>G,p.C634W	0.0005985	0.0002805	6743|4	7971|2	0.00096	30118|29	10	43609950	43609950	C	G	strand_bias,weak_evidence	RET	NM_020975.6	11	c.1902C>G	p.Cys634Trp	missense_variant	Pathogenic		Pheochromocytoma|Medullary_thyroid_carcinoma|Neoplasm_of_the_thyroid_gland|Multiple_endocrine_neoplasia,_type_1|Multiple_endocrine_neoplasia,_type_2b|Multiple_endocrine_neoplasia,_type_2a|Multiple_endocrine_neoplasia,_type_4|Hereditary_cancer-predisposing_syndrome|Multiple_endocrine_neoplasia,_type_2|not_provided	38	0.0
	KAT6B(0.3%)	exon16,c.3288_3293del,p.E1097_E1098del	0.003038	0.0005344	3049|7	4545|2	0.00311	9936|31	10	76781899	76781905	AGAAGAG	A	low_allele_frac	KAT6B	NM_012330.4	16	c.3288_3293del	p.Glu1097_Glu1098del	disruptive_inframe_deletion				45	0.0
-	PTEN(17.4%)	exon8,c.802-3del	0.174	0.111	37|18	110|41	0.14595	158|27	10	89720633	89720634	CT	C	germline,multiallelic,normal_artifact,slippage,Germline	PTEN	NM_000314.8	7	c.802-3del		splice_region_variant&intron_variant	Benign/Likely_benign		Hereditary_cancer-predisposing_syndrome|PTEN_hamartoma_tumor_syndrome|not_specified|Breast_and/or_ovarian_cancer|not_provided	20	0.0
-	PTEN(37.7%)	exon8,c.802-3dup	0.377	0.381	37|37	110|97	0.34979	158|85	10	89720633	89720634	CT	CTT	germline,multiallelic,normal_artifact,slippage,distinguished	PTEN	NM_000314.8	7	c.802-3dup		splice_acceptor_variant&intron_variant	Benign		PTEN_hamartoma_tumor_syndrome|not_specified|not_provided	29	0.0
-	PTEN(8.0%)	exon8,c.802-4_802-3dup	0.08	0.071	37|10	110|28	0.11236	158|20	10	89720633	89720634	CT	CTTT	germline,multiallelic,normal_artifact,slippage	PTEN	NM_000314.8	7	c.802-4_802-3dup		splice_acceptor_variant&intron_variant	Benign/Likely_benign		Hereditary_cancer-predisposing_syndrome|not_specified	20	0.0
	CD3G(4.1%)	exon3,c.213del,p.K71fs	0.041	0.051	1429|68	2827|175	0.04104	2991|128	11	118220582	118220583	TA	T	multiallelic,normal_artifact,slippage,suspected_bg	CD3G	NM_000073.3	3	c.213del	p.Lys71fs	frameshift_variant	Conflicting_interpretations_of_pathogenicity	Pathogenic(1)|_Uncertain_significance(1)	Immunodeficiency_17	46	0.0
	CD3G(1.8%)	exon3,c.213dup,p.W72fs	0.018	0.011	1429|34	2827|59	0.02287	2991|70	11	118220582	118220583	TA	TAA	multiallelic,normal_artifact,slippage,suspected_bg	CD3G	NM_000073.3	3	c.213dup	p.Trp72fs	frameshift_variant	Pathogenic		Immunodeficiency_17	43	0.0
	CHD4(7.3%)	exon4,c.358_378del,p.L120_K126del	0.073	0.018	52|3	62|0	0.06667	42|3	12	6711185	6711206	TCTTCTCTTTCTTAGGTCCAAG	T	clustered_events	CHD4	NM_001273.5	4	c.358_378del	p.Leu120_Lys126del	conservative_inframe_deletion				45	0.0
1	KRAS(0.1%)	exon4,c.436G>C,p.A146P	0.001208	0.0001943	2508|3	7135|0	0.00080	12502|10	12	25378562	25378562	C	G	orientation,strand_bias,weak_evidence	KRAS	NM_033360.4	4	c.436G>C	p.Ala146Pro	missense_variant	Likely_pathogenic		Multiple_myeloma|Neoplasm_of_the_large_intestine|Rasopathy	44	0.0
1	KRAS(0.1%)	exon3,c.181C>A,p.Q61K	0.001044	0.000181	3015|3	8020|0	0.00143	14708|21	12	25380277	25380277	G	T	clustered_events,weak_evidence	KRAS	NM_033360.4	3	c.181C>A	p.Gln61Lys	missense_variant	Pathogenic		Non-small_cell_lung_carcinoma|Neoplasm_of_the_thyroid_gland|Neoplasm_of_the_large_intestine	32	0.0
1	KRAS(0.2%)	exon3,c.176C>A,p.A59E	0.001957	0.0001808	2897|6	7729|1	0.00164	14013|23	12	25380282	25380282	G	T	clustered_events,orientation,weak_evidence	KRAS	NM_033360.4	3	c.176C>A	p.Ala59Glu	missense_variant				50	0.0
1	KRAS(0.1%)	exon3,c.175G>T,p.A59S	0.001285	0.0006597	2880|3	7719|6	0.00181	13206|24	12	25380283	25380288	C	A	clustered_events,normal_artifact,weak_evidence	KRAS	NM_033360.4	3	c.175G>T	p.Ala59Ser	missense_variant	Pathogenic/Likely_pathogenic		not_provided	57	0.0
1	KRAS(0.1%)	exon2,c.37G>T,p.G13C	0.0009151	0.0002175	3641|3	9437|1	0.00079	15265|12	12	25398282	25398282	C	A	clustered_events,orientation,weak_evidence	KRAS	NM_033360.4	2	c.37G>T	p.Gly13Cys	missense_variant	Pathogenic		Non-small_cell_lung_carcinoma|Neoplasm_of_the_large_intestine|RAS-associated_autoimmune_leukoproliferative_disorder|not_provided	29	0.0
1	KRAS(0.1%)	exon2,c.37G>A,p.G13S	0.0009897	0.0001809	3641|3	9437|1	0.00052	15265|8	12	25398282	25398282	C	T	clustered_events,orientation,weak_evidence	KRAS	NM_033360.4	2	c.37G>A	p.Gly13Ser	missense_variant	Pathogenic		Non-small_cell_lung_carcinoma|Neoplasm_of_the_thyroid_gland|Neoplasm_of_the_large_intestine	14	0.0
1	KRAS(0.1%)	exon2,c.34G>T,p.G12C	0.001206	0.0002482	3621|5	9431|3	0.00138	15233|21	12	25398285	25398285	C	A	clustered_events,weak_evidence	KRAS	NM_033360.4	2	c.34G>T	p.Gly12Cys	missense_variant	Conflicting_interpretations_of_pathogenicity	Pathogenic(7)|_Likely_pathogenic(1)|_Uncertain_significance(1)	Endometrial_carcinoma|Lung_adenocarcinoma|Non-small_cell_lung_carcinoma|Neoplasm_of_the_thyroid_gland|Neoplasm_of_ovary|Neoplasm_of_the_large_intestine|Lung_carcinoma|Gallbladder_cancer|not_provided	28	0.0
-	BRCA2(3.1%)	exon10,c.1813del,p.I605fs	0.031	0.02	1101|41	2185|54	0.02613	2050|55	13	32907420	32907421	GA	G	normal_artifact,slippage,suspected_bg	BRCA2	NM_000059.4	10	c.1813del	p.Ile605fs	frameshift_variant	Pathogenic		Hereditary_breast_and_ovarian_cancer_syndrome|Fanconi_anemia,_complementation_group_D1|Breast-ovarian_cancer,_familial_2|Hereditary_cancer-predisposing_syndrome|not_provided	41	0.0
-	BRCA2(2.7%)	exon23,c.9097dup,p.T3033fs	0.027	0.022	602|19	1642|42	0.02464	1029|26	13	32954022	32954022	C	CA	normal_artifact,slippage,suspected_bg	BRCA2	NM_000059.4	23	c.9097dup	p.Thr3033fs	frameshift_variant	Pathogenic		Carcinoma_of_breast|Neoplasm_of_ovary|Hereditary_breast_and_ovarian_cancer_syndrome|Malignant_tumor_of_breast|Breast-ovarian_cancer,_familial_1|Breast-ovarian_cancer,_familial_2|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|Breast_and/or_ovarian_cancer|not_provided	34	0.0
	NBEA(1.2%)	exon22,c.3362dup,p.N1121fs	0.012	0.011	2603|45	5296|74	0.01532	6878|107	13	35733662	35733662	T	TA	haplotype,normal_artifact,slippage,suspected_bg	NBEA	NM_015678.5	22	c.3362dup	p.Asn1121fs	frameshift_variant	Likely_pathogenic		Neurodevelopmental_disorder_with_or_without_early-onset_generalized_epilepsy	39	0.0
-	RB1(3.1%)	exon7,c.608-4del	0.031	0.03	3142|123	4876|175	0.03073	14887|472	13	48934140	48934141	AT	A	multiallelic,normal_artifact,slippage,suspected_bg	RB1	NM_000321.3	6	c.608-4del		splice_region_variant&intron_variant	Benign/Likely_benign		Retinoblastoma|Hereditary_cancer-predisposing_syndrome|not_provided	41	0.0
-	RB1(3.0%)	exon7,c.608-4dup	0.03	0.031	3142|133	4876|190	0.05124	14887|804	13	48934140	48934141	AT	ATT	multiallelic,normal_artifact,slippage,suspected_bg	RB1	NM_000321.3	6	c.608-4dup		splice_region_variant&intron_variant	Benign		Retinoblastoma	43	0.0
	BLM(2.0%)	exon7,c.1544del,p.N515fs	0.02	0.022	4072|113	7386|233	0.02375	18373|447	15	91304138	91304139	GA	G	multiallelic,normal_artifact,suspected_bg	BLM	NM_000057.4	7	c.1544del	p.Asn515fs	frameshift_variant	Pathogenic		Bloom_syndrome	41	0.0
	BLM(1.6%)	exon7,c.1544dup,p.N515fs	0.016	0.018	4072|93	7386|162	0.02691	18373|508	15	91304138	91304139	GA	GAA	multiallelic,normal_artifact,suspected_bg	BLM	NM_000057.4	7	c.1544dup	p.Asn515fs	frameshift_variant	Pathogenic/Likely_pathogenic		Hereditary_breast_and_ovarian_cancer_syndrome|Bloom_syndrome|Hereditary_cancer-predisposing_syndrome	38	0.0
	BLM(0.2%)	exon7,c.1546G>T,p.E516*	0.002405	0.0001633	4502|11	8237|2	0.00327	20135|66	15	91304149	91304149	G	T	orientation,strand_bias,low_allele_frac	BLM	NM_000057.4	7	c.1546G>T	p.Glu516*	stop_gained	Pathogenic		Bloom_syndrome	36	0.0
2	BLM(0.2%)	exon12,c.2407-4C>A	0.001918	0.0003218	6759|14	7899|2	0.00396	33453|133	15	91312664	91312664	C	A	strand_bias,low_allele_frac	BLM	NM_000057.4	11	c.2407-4C>A		splice_region_variant&intron_variant				48	0.0
	CHD2(5.8%)	exon29,c.3734del,p.K1245fs	0.058	0.049	332|19	759|44	0.03593	483|18	15	93540315	93540316	GA	G	multiallelic,normal_artifact,slippage,suspected_bg	CHD2	NM_001271.4	29	c.3734del	p.Lys1245fs	frameshift_variant&splice_region_variant	Pathogenic/Likely_pathogenic		Developmental_and_epileptic_encephalopathy_94|History_of_neurodevelopmental_disorder|not_provided	32	0.0
	CHD2(3.4%)	exon29,c.3734dup	0.034	0.039	332|12	759|39	0.03976	483|20	15	93540315	93540316	GA	GAA	multiallelic,normal_artifact,slippage,suspected_bg	CHD2	NM_001271.4	29	c.3734dup		splice_donor_variant&intron_variant	Conflicting_interpretations_of_pathogenicity	Pathogenic(1)|_Likely_benign(1)	Developmental_and_epileptic_encephalopathy_94	38	0.0
	CREBBP(0.4%)	exon14,c.2761G>T,p.A921S	0.003518	0.001268	1087|4	955|0	0.00401	1738|7	16	3820690	3820690	C	A	strand_bias,low_allele_frac	CREBBP	NM_004380.3	14	c.2761G>T	p.Ala921Ser	missense_variant				44	0.0
	CDH5(0.3%)	exon3,c.369G>T,p.V123=	0.00273	0.0006166	4023|12	4134|4	0.00435	9153|40	16	66420870	66420870	G	T	low_allele_frac	CDH5	NM_001795.5	3	c.369G>T	p.Val123=	synonymous_variant				36	0.0
	TP53(49.6%)	exon6,c.638G>T,p.R213L	0.496	0.0002918	3767|3641	7377|7	0.48865	13758|13147	17	7578211	7578211	C	A	PASS	TP53	NM_000546.6	6	c.638G>T	p.Arg213Leu	missense_variant	Uncertain_significance		Hepatocellular_carcinoma|Adrenocortical_carcinoma|Pancreatic_adenocarcinoma|Squamous_cell_carcinoma_of_the_skin|Transitional_cell_carcinoma_of_the_bladder|Breast_neoplasm|Carcinoma_of_esophagus|Renal_cell_carcinoma,_papillary,_1|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Squamous_cell_lung_carcinoma|Neoplasm_of_brain|Adenocarcinoma_of_stomach|Nasopharyngeal_Neoplasms|Neoplasm_of_the_large_intestine|Adenoid_cystic_carcinoma|Adenocarcinoma_of_prostate|Ovarian_Serous_Cystadenocarcinoma|Uterine_Carcinosarcoma|Squamous_cell_carcinoma_of_the_head_and_neck|Glioblastoma|Li-Fraumeni_syndrome|Malignant_neoplasm_of_body_of_uterus	43	0.0
	FLCN(14.2%)	exon11,c.1285del,p.H429fs	0.142	0.092	44|7	62|6	0.11864	52|7	17	17119708	17119709	TG	T	normal_artifact,slippage,weak_evidence	FLCN	NM_144997.7	11	c.1285del	p.His429fs	frameshift_variant	Pathogenic		Multiple_fibrofolliculomas|Hereditary_cancer-predisposing_syndrome|not_specified|not_provided	44	0.0
-	RNF43(1.9%)	exon9,c.1976del,p.G659fs	0.019	0.023	896|26	901|27	0.01807	1467|27	17	56435160	56435161	AC	A	normal_artifact,weak_evidence,suspected_bg	RNF43	NM_017763.6	9	c.1976del	p.Gly659fs	frameshift_variant	Likely_pathogenic		Sessile_serrated_polyposis_cancer_syndrome	46	0.0
	USP36(0.3%)	exon17,c.3017G>A,p.R1006H	0.00324	0.002546	2862|9	2303|5	0.00383	13005|50	17	76798411	76798411	C	T	background,low_allele_frac	USP36	NM_001321291.2	17	c.3017G>A	p.Arg1006His	missense_variant				32	0.0
	KEAP1(0.7%)	exon3,c.952C>T,p.P318S	0.007033	0.001381	967|7	898|1	0.01658	1483|25	19	10602626	10602626	G	A	suspected_bg,low_allele_frac	KEAP1	NM_203500.2	3	c.952C>T	p.Pro318Ser	missense_variant				53	0.0
	BRD4(0.2%)	exon8,c.1401C>A,p.A467=	0.002334	0.0005573	5659|14	5937|3	0.00324	17520|57	19	15367925	15367925	G	T	low_allele_frac	BRD4	NM_058243.3	8	c.1401C>A	p.Ala467=	synonymous_variant				42	0.0
	BAX(2.2%)	exon3,c.121del,p.E41fs	0.022	0.02	3726|99	3234|85	0.02364	9622|233	19	49458970	49458971	TG	T	multiallelic,normal_artifact,slippage,suspected_bg	BAX	NM_138761.4	3	c.121del	p.Glu41fs	frameshift_variant	Pathogenic		Carcinoma_of_colon	38	0.0
	RBM10(15.8%)	exon9,c.803G>A,p.G268D	0.158	0.111	21|4	9|0	0.16000	21|4	X	47038796	47038796	G	A	orientation	RBM10	NM_005676.5	9	c.803G>A	p.Gly268Asp	missense_variant				37	0.0
